Form 8-K · Current report
News Corp 8-K, filed Nov 4, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000243
Summary
News Corp repurchased 58,482 Class A shares for US$1,726,517.30 on Nov 3, 2026 under its 2025 Repurchase Program, putting cumulative purchases at roughly US$568 million of the US$1 billion authorized. The company said the buy-back is intended to enhance shareholder value.
Key points
- News Corp bought back 58,482 Class A shares on Nov 3, 2026 for US$1,726,517.30, at prices between US$29.06 and US$29.69.
- Cumulative repurchases under the program total 14,008,731 shares for US$371,877,199.62, with approximately US$567,986,584 of stock purchased against the US$1 billion authorization.
- The 2025 Repurchase Program, authorized July 15, 2025, covers Nasdaq-listed Class A and Class B common stock; no ASX-listed CDIs will be repurchased.
- The company states the buy-back's purpose is to enhance shareholder value and that it has no obligation to update forward-looking statements about the program.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.